Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 09 Jun 2021 for Allscripts Healthcare Solutions, INC., €415k. Read the official filing
Filing timeline
BuySaleMichael Klayko
Insider track record
Disclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Michael Klayko: trading record in brief
Michael Klayko is a declared insider at 2 companies (board member); the most frequent names are Veradigm Inc. and PMC Sierra Inc. Between 15 January 2016 and 8 June 2021, the trades on record add up to 4 filings.
The open-market record consists of 2 sales worth €2.1M, with no purchase. Outside the open market, there are 1 share grant. Since January 2021: no purchases and 2 sales on the market.
The record was last updated on 9 June 2021 with an open-market sale (€415k) in Veradigm Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Michael Klayko
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
28,000 shares@ US$18.03419.8% of flowCommon StockSEC:0001209191-21-039181:0
113,000 shares@ US$18.00180.2% of flowCommon StockSEC:0001209191-21-038407:0
12,056 shares0Common StockSEC:0001209191-21-036272:0
16,015 sharesCommon StockSEC:0001209191-16-092277:0
4 of 4 declarations
